NSE · AI Signal & Stock Analysis · Neutral
As of Sep 28 2026, 6:47 PM, AkshayaAI's signal for COHANCE is Neutral → (mild move); technical trend raise-2026-08-17; trading at ₹456.60 (-0.92% today); neutral (RSI 53).
Data as of Sep 28 2026, 6:47 PM. Informational analytics only — not investment advice.
| AI signal | Neutral → · Mild move |
|---|---|
| Technical trend | RAISE-2026-08-17 |
| Price | ₹456.60 |
| Change today | -0.92% |
| RSI (14) | 53.20 |
| Relative volume | 0.35 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹17,343 Cr |
| P/E | 164.24 |
| Cap category | Mid Cap |
| 52-week high | -55.2% away |
| 52-week low | +63.1% above |
| Delivery volume | — |
| Sector | Drug Manufacturers - Specialty & Generic |
As of Sep 28 2026, 6:47 PM, AkshayaAI's signal for COHANCE (Cohance Lifesciences Limited) is Neutral with a mild move, and its technical trend is raise-2026-08-17. The composite score and full factor breakdown are available to signed-in members.
COHANCE's RSI is neutral (RSI 53). A reading above 70 is typically overbought and below 30 oversold.
COHANCE is trading about 55% below its 52-week high and 63% above its 52-week low as of Sep 28 2026, 6:47 PM.
COHANCE's market capitalisation is ₹17,343 Cr as of Sep 28 2026, 6:47 PM.
COHANCE is classified under Drug Manufacturers - Specialty & Generic in AkshayaAI's taxonomy.
AkshayaAI refreshes its signals daily. The figures on this page are timestamped as of the latest run shown above.
No. AkshayaAI provides informational, AI-generated analytics for COHANCE — not personalised investment advice. Always do your own research.
AARTIPHARM · ABBOTINDIA · AJANTPHARM · AKUMS · ALIVUS · ALKEM
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Sep 28 2026, 6:47 PM and may not reflect real-time prices. Always do your own research. How these signals work →
Instant, data-backed answers — free to try.